In collaboration with the World Parkinson Coalition, Parkinson Society British Columbia (PSBC) is launching the "Parkinson Ready" training program to promote informed care and increase awareness of Parkinson's disease (PD). This initiative is led by an individual with...
We are excited to announce a new drop-in service at the Kelowna Movement Disorder Clinic, offering timely advice and expert direction for Parkinson's resources. The team of Social Workers, Speech-Language Pathologists, and Physical Therapists is available to support...
Parkinson Society British Columbia (PSBC) is pleased to announce the appointment of Dr. Joanne Baker (PhD) as the new Chief Executive Officer (CEO),
In response to the discontinuation of Movapo, an essential medication for managing hypomobility in advanced Parkinson’s disease, Canadians now have access to an alternative treatment option. APO-go® PEN, containing the ingredient apomorphine hydrochloride, has been...
Parkinson Society British Columbia (PSBC) is calling for nominations to honor individuals within the Parkinson's community who actively engage in volunteer opportunities with the organization. These dedicated individuals lead, facilitate, or support various PSBC...
Parkinson Society BC (PSBC) is committed to providing comprehensive support to those affected by Parkinson's disease, recognizing the complexities and challenges of the journey for both the individuals diagnosed and their loved ones. With a focus on holistic care,...
Last year, Paul Gully and Lois Leslie departed on a cycling trip called Shifting Gears for Parkinson's. This trip began in Lisbon, Portugal and is scheduled to end in Auckland, New Zealand in late 2018. During the course of this journey, their goal is to raise funds...
Parkinson Society British Columbia (PSBC) is pleased to share the Canadian-Open Parkinson Network (C-OPN) Annual Report 2023. This report details the achievements in Parkinson’s disease (PD) research facilitated by C-OPN, underscoring the collective efforts of...
The introduction of VYALEV™ (foslevodopa/foscarbidopa solution) in Canada marks an advancement for those living with Parkinson's disease (PD). This new subcutaneous 24-hour infusion therapy is now available for the treatment of motor fluctuations in patients with...
